$0.35 EPS Expected for Hollysys Automation Technologies Ltd. (HOLI); 3 Analysts Bullish Alliance Pharma plc (LON:APH)

April 17, 2018 - By Hazel Jackson

Alliance Pharma plc (LON:APH) Logo

Among 4 analysts covering Alliance Pharma PLC (LON:APH), 3 have Buy rating, 1 Sell and 0 Hold. Therefore 75% are positive. Alliance Pharma PLC had 24 analyst reports since September 9, 2015 according to SRatingsIntel. Numis Securities maintained the stock with “Buy” rating in Wednesday, September 14 report. The rating was maintained by Numis Securities with “Buy” on Thursday, January 21. The stock of Alliance Pharma plc (LON:APH) has “Buy” rating given on Thursday, April 7 by Numis Securities. The firm has “Buy” rating given on Monday, July 31 by FinnCap. The firm has “Buy” rating given on Thursday, March 30 by Numis Securities. The stock has “Buy” rating by Investec on Wednesday, September 13. FinnCap maintained it with “Buy” rating and GBX 58 target in Tuesday, November 21 report. The firm has “Buy” rating by Numis Securities given on Tuesday, July 19. Numis Securities maintained Alliance Pharma plc (LON:APH) rating on Monday, January 23. Numis Securities has “Buy” rating and GBX 60 target. The firm earned “Buy” rating on Friday, June 24 by Numis Securities. See Alliance Pharma plc (LON:APH) latest ratings:

22/01/2018 Broker: Numis Securities Rating: Add Old Target: GBX 80.00 New Target: GBX 80.00 Maintain
12/12/2017 Broker: FinnCap Rating: Buy Old Target: GBX 58.00 New Target: GBX 70.00 Maintain
04/12/2017 Broker: Numis Securities Rating: Buy New Target: GBX 71.00 Maintain
01/12/2017 Broker: Numis Securities Rating: Buy New Target: GBX 66.00 Maintain
21/11/2017 Broker: FinnCap Rating: Buy Old Target: GBX 58.00 New Target: GBX 58.00 Maintain

Analysts expect Hollysys Automation Technologies Ltd. (NASDAQ:HOLI) to report $0.35 EPS on May, 10.They anticipate $0.13 EPS change or 59.09% from last quarter’s $0.22 EPS. HOLI’s profit would be $21.12 million giving it 17.30 P/E if the $0.35 EPS is correct. After having $0.60 EPS previously, Hollysys Automation Technologies Ltd.’s analysts see -41.67% EPS growth. The stock increased 0.73% or $0.175 during the last trading session, reaching $24.215. About 94,736 shares traded. Hollysys Automation Technologies Ltd. (NASDAQ:HOLI) has risen 48.73% since April 17, 2017 and is uptrending. It has outperformed by 37.18% the S&P500.

It closed at GBX 76.6 lastly. It is up 0.00% since April 17, 2017 and is . It has underperformed by 11.55% the S&P500.

Alliance Pharma plc operates as a specialty pharmaceutical firm in Europe and internationally. The company has market cap of 363.92 million GBP. It acquires the rights to established products, and owns or licenses the rights to approximately 90 pharmaceutical and consumer healthcare products. It has a 12.77 P/E ratio. The firm provides prescription only medicines, over the counter medications, cosmetics, and nutritional supplements, as well as medical devices.

Investors sentiment decreased to 0.91 in Q4 2017. Its down 0.04, from 0.95 in 2017Q3. It dived, as 25 investors sold Alliance Pharma plc shares while 209 reduced holdings. 53 funds opened positions while 159 raised stakes. 289.04 million shares or 1.12% less from 292.31 million shares in 2017Q3 were reported. Driehaus Capital Ltd Limited Liability Company holds 2,491 shares or 0.01% of its portfolio. Metropolitan Life Co accumulated 0.07% or 59,953 shares. State Board Of Administration Of Florida Retirement Systems reported 0.1% stake. Ameriprise stated it has 0.06% in Alliance Pharma plc (LON:APH). Twin Capital Management stated it has 0.05% in Alliance Pharma plc (LON:APH). Macguire Cheswick And Tuttle Inv Counsel Limited Co accumulated 189,517 shares. Acadian Asset Mngmt Ltd Liability Company invested 0.01% in Alliance Pharma plc (LON:APH). Reilly Advisors Limited Liability holds 1.7% in Alliance Pharma plc (LON:APH) or 136,332 shares. Moneta Group Investment Limited Liability reported 7,405 shares. Highvista Strategies Lc holds 0.16% or 6,700 shares in its portfolio. Nordea stated it has 0.01% in Alliance Pharma plc (LON:APH). Macquarie Gru holds 0% of its portfolio in Alliance Pharma plc (LON:APH) for 13,333 shares. Pillar Pacific Mngmt Ltd Co reported 16,325 shares. Moreover, Foundry Prtn Limited Liability has 0.04% invested in Alliance Pharma plc (LON:APH). Wedge Mngmt L Limited Partnership Nc reported 0.54% of its portfolio in Alliance Pharma plc (LON:APH).

Since October 27, 2017, it had 0 insider buys, and 3 selling transactions for $27.46 million activity. On Monday, October 30 the insider NORWITT RICHARD ADAM sold $18.94 million. Gavelle Jean-Luc also sold $7.60 million worth of Alliance Pharma plc (LON:APH) shares. Another trade for 10,000 shares valued at $920,699 was sold by D’AMICO LANCE E.

Among 5 analysts covering HollySys (NASDAQ:HOLI), 0 have Buy rating, 0 Sell and 5 Hold. Therefore 0 are positive. HollySys had 9 analyst reports since December 17, 2015 according to SRatingsIntel. As per Monday, February 12, the company rating was maintained by JP Morgan. The company was upgraded on Tuesday, May 24 by Nomura. The firm earned “Neutral” rating on Friday, January 8 by Credit Suisse. The rating was downgraded by J.P. Morgan to “Hold” on Friday, February 9. As per Thursday, April 28, the company rating was downgraded by Nomura. Goldman Sachs downgraded the stock to “Neutral” rating in Thursday, December 17 report. The stock has “Neutral” rating by JP Morgan on Thursday, February 18.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Hazel Jackson

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: